Evidence map›Paper›PMID 22159421›Full record

ArticleJournal of cell science2011

WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.

Birija Sankar Patro, Rikke Frøhlich, Vilhelm A Bohr, Tinna Stevnsner

Abstract read
In one paragraph

Article in Journal of cell science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. R-Loop-Associated Genomic Instability and Implication of WRN and WRNIP1.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. RecQ DNA Helicase Rqh1 Promotes Rad3Molecular and cellular biology · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Replication stress: getting back on track.Nature structural & molecular biology · 2016
    Review
  15. Review
  16. Article
  17. Review
  18. Checkpoint regulation of replication forks: global or local?Biochemical Society transactions · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Birija Sankar PatroDepartment of Molecular Biology, University of Aarhus, C. F. Mollers Alle 3, DK-8000 Aarhus C, Denmark.
Rikke Frøhlich
Vilhelm A Bohr
Tinna Stevnsner
Aarhus University · DKNational Institute on Aging · US

Funding

The Function of Werner Syndrome ProteinZIAAG000721 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2022
$7.7M
Intramural NIH HHSNCCDPHP CDC HHS U48 DP005024
6 · The paper itself

Abstract

Checkpoints are cellular surveillance and signaling pathways that coordinate the response to DNA damage and replicative stress. Consequently, failure of cellular checkpoints increases susceptibility to DNA damage and can lead to profound genome instability. This study examines the role of a human RECQ helicase, WRN, in checkpoint activation in response to DNA damage. Mutations in WRN lead to genomic instability and the premature aging condition Werner syndrome. Here, the role of WRN in a DNA-damage-induced checkpoint was analyzed in U-2 OS (WRN wild type) and isogenic cells stably expressing WRN-targeted shRNA (WRN knockdown). The results of our studies suggest that WRN has a crucial role in inducing an S-phase checkpoint in cells exposed to the topoisomerase I inhibitor campthothecin (CPT), but not in cells exposed to hydroxyurea. Intriguingly, WRN decreases the rate of replication fork elongation, increases the accumulation of ssDNA and stimulates phosphorylation of CHK1, which releases CHK1 from chromatin in CPT-treated cells. Importantly, knockdown of WRN expression abolished or delayed all these processes in response to CPT. Together, our results strongly suggest an essential regulatory role for WRN in controlling the ATR-CHK1-mediated S-phase checkpoint in CPT-treated cells.

Indexed as

S Phase Cell Cycle CheckpointsAtaxia Telangiectasia Mutated ProteinsCamptothecinCell Cycle ProteinsCell Line, TumorCheckpoint Kinase 1ChromatinChromatin ImmunoprecipitationDNA DamageDNA ReplicationDNA, Single-StrandedExodeoxyribonucleasesGene Expression Regulation, EnzymologicGene Knockdown TechniquesGenomic InstabilityHumansAtaxia Telangiectasia Mutated ProteinsATR protein, humanCamptothecinCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanChromatinDNA, Single-StrandedExodeoxyribonucleasesHydroxyureaProtein KinasesProtein Serine-Threonine KinasesRecQ HelicasesRNA, Small InterferingTopoisomerase I InhibitorsWerner Syndrome HelicaseWRN protein, human

Identifiers

PMID22159421
PMCPMC3244981
OpenAlexW2006332057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.